REFERRALS TO HEMATOLOGICAL CONSULTATIONS FOR EOSINOPHILIA – DIFFERENCES BETWEEN GENERAL AND UNIVERSITY HOSPITAL PATIENTS.

EHA Library, Hrvoje Holik, 216859

PLASMA LEVELS OF SOME HEMOSTATIC MARKERS IN PATIENTS WITH ACUTE CORONARY SYNDROMES

EHA Library, Yuliya Tyravska, 216846

COMBINED ORAL ADMINISTRATION OF ANALGESIA AND ANXIOLYSIS FOR PAIN ASSOCIATED WITH BONE MARROW ASPIRATION AND BIOPSY

EHA Library, Claudio Cerchione, 216878

ACTIONS THAT MAKE ANTICOAGULANT THERAPY SAFER: 10 YEARS ON - DO WE COMPLY? EVALUATING WARFARIN USE AND APPROPRIATENESS AT A LONDON ACUTE HOSPITAL

EHA Library, Drew Harding, 216877

COST OF HEMATOLOGIC CANCERS IN INDIA: A HOSPITAL INPATIENT CARE ANALYSIS

EHA Library, Chepsy Cherian Philip, 216876

PHARMACOECONOMIC EVALUATION OF MANAGEMENT OF DASATINIB AND IMATINIB THERAPY SIDE EFFECTS IN CHRONIC MYELOID LEUKEMIA. MULTICENTRIC RETROSPECTIVE STUDY.

EHA Library, GIULIO GIORDANO, 216875

EVALUATION OF FERRIC MALTOL AS ALTERNATIVE TO PARENTERAL IRON THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) IN TERMS OF COSTS REDUCTIONS AND HEALTHCARE HUMAN RESOURCE UTILISATION

EHA Library, Silvia Lovato, 216874

THE OTHER SIDE OF THE MOON: PATIENTS’ PERCEPTION OF IMATINIB AND DASATINIB SYMPTOM BURDEN FOR CHRONIC MYELOID LEUKEMIA. RESULTS OF THE PATIENT’S JOURNEY FROM THE REAL-LIFE SOLARIS PROJECT

EHA Library, Fabio Stagno, 216873

STRONG ASSOCIATION BETWEEN HERPES SIMPLEX VIRUS AND CHEMOTHERAPY-INDUCED ORAL MUCOSITIS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES UNDERGOING INTENSIVE CHEMOTHERAPY OR STEM CELL TRANSPLANTATION

EHA Library, Junshik Hong, 216872

HEALTH-RELATED QUALITY OF LIFE IN CAREGIVER OF HEMOPHILIA PATIENTS

EHA Library, Gonzalo Ferrer Garrido, 216871

KNOWLEDGE, CULTURAL, AND STRUCTURAL BARRIERS TO THALASSEMIA SCREENING IN MIGRANT POPULATIONS IN THAILAND

EHA Library, Julia Xu, 216870

PREVALENCE OF ANXIETY AND DEPRESSION AMONG CAREGIVERS OF CANCER PATIENTS IN MALAYSIA

EHA Library, Kevin Tey Wen Fei, 216869

PROFILE OF "OLDEST OLD" PATIENTS WITH ANEMIA IN A HEMATOLOGY-GERIATRIC INTERDISCIPLINARY CONSULTATION.

EHA Library, Laura Lacalle, 216868

TIME FROM SYMPTOM ONSET TO DIAGNOSIS AND TREATMENT AMONG HEMATOLOGICAL MALIGNANCIES: DISEASE, PATIENT AND HEALTH SYSTEM RELATED INFLUENCING FACTORS

EHA Library, Austėja Dapkevičiūtė, 216867

PREVALENCE OF METABOLIC SYNDROME AND SARCOPENIA AS LONG-TERM LATE EFFECTS IN LYMPHOMA SURVIVORS

EHA Library, Antonella Daniele, 216866

MONTELUKAST AND GEMFIBROZIL IMPROVES SYMPTOM CONTROL AND ENHANCES THE RESPONSE TO ORAL CHEMOTHERAPY IN HAEMATOLOGICAL MALIGNANCIES WITH A POOR PROGNOSIS.

EHA Library, Stephen O'Mara, 216865

RESULTS OF A MULTICENTER UNIVERSAL NEWBORN SCREENING PROGRAM FOR SICKLE CELL DISEASE IN ITALY: A CALL TO ACTION

EHA Library, R Colombatti, 216864

TREATMENT PATTERN AND UNMET NEED IN ADULTS WITH PHILADELPHIA POSITIVE (PH+) RELAPSED OR REFRACTORY (R/R) B-CELL PRECURSOR (BCP) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IN EU-5 COUNTRIES.

EHA Library, Xinke Zhang, 216863

TERTIARY PREVENTION FOR PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Pavel Kotoucek, 216862

A REVIEW OF CLINICAL PRACTICE REGARDING DNACPR DECISION MAKING, DISCUSSION AND IMPLEMENTATION

EHA Library, Anneka Burge, 216861

REAL‐WORLD UTILIZATION OF MULTIPLE MYELOMA TREATMENTS IN THE ERA OF NOVEL THERAPIES: WHAT IS THE CURRENT STANDARD OF CARE?

EHA Library, Eric Maiese, 216860

GENETIC POLYMORPHISMS AS RISK FACTORS OF ENDOTHELIAL DYSFUNCTION IN PREGNANT WOMEN

EHA Library, Natalia Korsakova, 216847

QUALITATIVE STUDY INVESTIGATING THE PERCEPTIONS OF MYELOPROLIFERATIVE NEOPLASM PATIENTS PARTICIPATING IN AN ONLINE YOGA INTERVENTION

EHA Library, Jennifer Huberty, 216858

INFLUENCE OF ABO BLOOD GROUP ON VON WILLEBRAND FACTOR TESTS IN HEALTHY SAUDI BLOOD DONORS

EHA Library, Salwa Bakr, 216857

QUALITY OF LIFE OF PATIENTS WITH TYPE 1 GAUCHER DISEASE AFTER LONG-TERM ENZYME REPLACEMENT THERAPY

EHA Library, Hongmin Li, 216856

METABOLIC PROFILE OF CHILDREN AND ADOLESCENTS FOLLOWING TREATMENT FOR HEMATOLOGIC MALIGNANCIES

EHA Library, Despoina Apostolaki, 216855

QUALITY OF LIFE OF TRANSFUSION DEPENDENT THALASSEMIA PATIENTS IN GREECE. A MULTICENTRE STUDY

EHA Library, Philippos Klonizakis, 216854

TEACHING HAEMATOLOGY TO MEDICAL STUDENTS: WHAT DO WE TEACH AND WHAT THEY WANT TO BE TAUGHT

EHA Library, Silvia Lovato, 216853

NEPA (NETUPITANT PLUS PALONOSETRON) FOR THE PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING IN PATIENTS RECEIVING STEM CELL TRANSPLANTATION

EHA Library, Mariana Corrochano, 216852

MYELOPROLIFERATIVE NEOPLASMS AND ACCEPTANCE AND COMMITMENT THERAPY: AN ONGOING FEASIBILITY STUDY AIMED AT SYMPTOM MITIGATION AND QUALITY OF LIFE

EHA Library, Leslie Padrnos, 216851

GENERAL HEALTH IN OLDER ADULTS WITH NON-HODGKIN LYMPHOMA USING A COMPREHENSIVE GERIATRIC ASSESSMENT

EHA Library, Daniel Mercante, 216850

THE CHANGE OF QUALITY OF LIFE IN 52 NON-SEVERE APLASTIC ANEMIA PATIENTS AFTER CYCLOSPORINE A THERAPY

EHA Library, Fangfei Chen, 216849

PAIN AND SERIOUS ADVERSE EVENT WITH BONE MARROW ASPIRATION AND BIOPSY: A SINGLE CENTRE EXPERIENCE FROM INDIA

EHA Library, Chepsy Cherian Philip, 216848

EHA23 Educational Updates in Hematology

EHA Library, EHA annual congress, 219399

EHA23 Abstract Book

EHA Library, EHA annual congress, 219320

TLS risk assessment with CLL therapies

EHA Library, John Gribben, 209967

TLS prophylaxis and monitoring

EHA Library, John Seymour, 209966

Clinical management of TLS

EHA Library, Barbara Eichhorst, 209965

A challenging course through a difficult landscape

EHA Library, Delivered by Janssen, 205759

HME FORUM The Clinical Implications of Our Improved Understanding Of CLL Biology

EHA Library, Delivered by Janssen, 202872

HME FORUM Optimizing Outcomes For Patients With CLL

EHA Library, Delivered by Janssen, 202871

Emerging treatment goals in chronic myeloid lymphoma

EHA Library, Delivered by Novartis, 202870

Registration form for mentors

EHA Library, Course Faculty, 196305

Treatment of Patients With Myelofibrosis and Uncontrolled Polycythemia Vera

EHA Library, Delivered by Novartis, 193789

ITP and AA: Our current understanding and what the future might hold

EHA Library, Delivered by Novartis, 192923

From biology to targeted therapies in chronic lymphocytic leukemia

EHA Library, Stephan Stilgenbauer, 184561

Hemophilia Treatment: Navigating Speed Bumps on the Innovation Highway

EHA Library, Donna DiMichele, 184560

INDUCTION OF HEMOGENIC REPROGRAMMING IN HUMAN FIBROBLASTS

EHA Library, Andreia Gomes, 183930

Managing CLL patients after BCR inhibitor failure

EHA Library, Jeffrey Jones, 184553

Harnessing T cells for Immunotherapy of AML

EHA Library, Marion Subklewe, 184556

New Treatment Approaches In Myeloma In 2017

EHA Library, Jesús San Miguel, 184549

Treatment Of Aggressive Lymphoma Focused On Elderly Patients

EHA Library, Michael Pfreundschuh, 184545

New drugs for old? What is the role of B-cell receptor pathway inhibition in the front line therapy of CLL in 2017?

EHA Library, Stephen Devereux, 184552

CRYPTIC INSERTIONS OF IMMUNOGLOBULIN LIGHT CHAIN ENHANCER REGIONS ACTIVATE CCND3 AND CCND2 IN CYCLIN D1-NEGATIVE MANTLE CELL LYMPHOMAS

EHA Library, Silvia Bea, 183929

Genetic Classification Of Myeloma For Prognostication And Treatment Selection

EHA Library, Hervé Avet-Loiseau, 184548

First-line therapy for CLL in 2017

EHA Library, Alessandra Tedeschi, 184551

Role of enhancers in the pathogenesis of AML

EHA Library, Ruud Delwel, 184555

Relapsed aggressive lymphoma: Can we optimize the therapy

EHA Library, Gilles Salles, 184544

BONE MARROW SITES DIFFERENTLY IMPRINT DORMANCY AND CHEMORESISTANCE TO T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Francoise Pflumio, 183931

ANTI-CD69 MAB TREATMENT INCREASES THE CAPACITY OF NK CELLS TO ELIMINATE HYPER-REACTIVE ALLOGENIC T CELLS AND PREVENTS ACUTE GRAFT VERSUS HOST DISEASE

EHA Library, Katerina Tsilingiri, 183933

Iron Chelation in Hemoglobinopathies 

EHA Library, Vip Viprakasit, 192910

ARNT/HIF-1BETA LINKS POOR CLINICAL OUTCOME TO MICROENVIRONMENTAL HYPOXIA AND HIGH-RISK 1Q GAIN IN MULTIPLE MYELOMA

EHA Library, Fengyan Jin, 183932

Immunopathology of MM

EHA Library, Nikhil Munshi, 184547

The Biological Basis Of Aggressive Lymphoma

EHA Library, Elias Campo, 184543

GLOBAL PIVOTAL PHASE 2 TRIAL OF THE CD19-TARGETED THERAPY CTL019 IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)—AN INTERIM ANALYSIS

EHA Library, Gilles Salles, 183934

GvL / GvHD

EHA Library, Fred Falkenburg, 192908

Indications For Transplantation In MDS

EHA Library, Matteo Giovanni Della Porta, 184533

Pregnancy during and after treatment. Myths and reality.

EHA Library, Jane APPERLEY, 192902

Red Cell Transfusion: When To Transfuse In Patients With Hematological Malignancies?

EHA Library, Miquel Lozano, 184537

Prioritisation Therapies In CLL

EHA Library, Clemens Wendtner, 184524

Heat Shock Protein 70 (HSP70), one of the major key factors in Diamond-Blackfan anemia

EHA Library, Lydie Da Costa, 184541

ELN-EHA-SWG on CML

EHA Library, Jerry Radich, 184529

Immune microenvironment in the pathogenesis of MDS

EHA Library, Shahram Kordasti, 184532

ELN-EHA-SWG on CML

EHA Library, Daniela Krause, 184528

Iron overload before, during and after bone marrow transplantation

EHA Library, Emanuele Angelucci, 184539

Prognostic Factors In CLL: When, Which And How?

EHA Library, Sarka Pospisilova, 184523

Challenges In Typing And Matching Strategies In Patients With Hematological Maligancies In The Era Of Immunotherapy

EHA Library, Karen Vooght, 184536

ELN-EHA-SWG on CML

EHA Library, Alois Gratwohl, 184527

Cell-derived Microvesicles And Microparticles In Blood Components: Consequences For Transfusion Recipients

EHA Library, Thierry Burnouf, 184535

Relevance Of Microenvironment In CLL

EHA Library, Federico Caligaris-Cappio, 184522

ELN-EHA-SWG on CML

EHA Library, Delphine Rea, 184526

Clonal Evolution In MDS

EHA Library, Joop Jansen, 184531

Transferrin and TfR1 in co-regulation of erythropoiesis and iron metabolism

EHA Library, Yelena Ginzburg, 184540

CARD9 CONTROLS DECTIN-1-INDUCED T-CELL CYTOTOXICITY AND TUMOR GROWTH IN MICE

EHA Library, Tobias Haas, 182105

EFFICACY AND SAFETY OF DEFIBROTIDE TO TREAT HEPATIC VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME (VOD/SOS) POST-CHEMOTHERAPY: A POST HOC ANALYSIS OF FINAL DATA OF AN EXPANDED-ACCESS PROTOCOL

EHA Library, Stephan Grupp, 182095

T-CELL RECEPTOR Β (TRB) REPERTOIRE CHARACTERISTICS IN RELAPSED/REFRACTORY (R/R) B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (BCP-ALL) ON BLINATUMOMAB TREATMENT.

EHA Library, Henrik Knecht, 182090

ALLOGENEIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA WITH DELETION 5Q OR MONOSOMY 5: A STUDY FROM THE ACUTE LEUKEMIA WORKING PARTY (ALWP) OF THE EBMT

EHA Library, Xavier Poiré, 182085

A PHASE 1B STUDY OF THE COMBINATION OF VADASTUXIMAB TALIRINE AND 7+3 INDUCTION THERAPY FOR PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Moshe Y. Levy, 182080

POOLED SURVIVAL ANALYSIS OF MIDOSTAURIN CLINICAL STUDY DATA (D2201 + A2213) IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS (ADVSM) COMPARED WITH HISTORICAL CONTROLS

EHA Library, Andreas Reiter, 182075

PEMBROLIZUMAB PLUS LENALIDOMIDE AND LOW-DOSE DEXAMETHASONE FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EFFICACY AND BIOMARKER RESULTS FROM THE PHASE 1 KEYNOTE-023 STUDY

EHA Library, Paula Rodríguez-Otero, 182070

13-YR FOLLOW UP OF MULTICENTER RANDOMIZED CHOP-R VS R-HDS TRIAL IN HIGH RISK FOLLICULAR LYMPHOMA PATIENTS: PROLONGED SURVIVAL AND HIGH RATE OF LONG-TERM DISEASE FREE SURVIVORS

EHA Library, Corrado Tarella, 182065

THE DUAL SYK/JAK INHIBITOR CERDULATINIB DEMONSTRATES COMPLETE INHIBITION OF SYK AND JAK AND RAPID TUMOR RESPONSES IN A PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY B CELL MALIGNANCIES

EHA Library, Paul Hamlin, 182060

DIFFERENT IRON SOURCES AND ACQUISITION PATHWAYS SHAPE MACROPHAGES TOWARDS OPPOSING FUNCTIONAL PHENOTYPES

EHA Library, Francesca Vinchi, 182100

POST-INDUCTION MRD PREDICTS HIGH RELAPSE RISK FOLLOWING REDUCED INTENSITY CONDITIONED ALLOGENEIC STEM CELL TRANSPLANTATION: A PROSPECTIVE STUDY OF ADULT ALL (UKALL14,ISRCTN 66541317)

EHA Library, Dina Okasha, 182089

CYCLOPHOSPHAMIDE VERSUS ETOPOSIDE IN COMBINATION WITH TOTAL BODY IRRADIATION AS CONDITIONING FOR ADULTS WITH PH(-) ALL UNDERGOING ALLO-HCT. A STUDY FROM THE ACUTE LEUKEMIA WORKING PARTY OF THE EBMT

EHA Library, Sebastian Giebel, 182084

SORAFENIB MAINTENANCE IN FLT3-ITD MUTATED ACUTE MYELOID LEUKEMIA AFTER ALLOGENEIC STEM CELL TRANSPLANT

EHA Library, Betul Oran, 182079

MOLECULAR RESPONSE TO HYDROXYUREA AND ROPEGINTERFERON ALFA-2B IN THE PROUD-PV RANDOMIZED PHASE 3 TRIAL

EHA Library, Jean-Jacques Kiladjian, 182074

COMPARISON OF DENOSUMAB (DMB) WITH ZOLEDRONIC ACID (ZA) FOR THE TREATMENT OF BONE DISEASE IN PATIENTS (PTS) WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; AN INTERNATIONAL, RANDOMIZED, DOUBLE BLIND TRIAL

EHA Library, Evangelos Terpos, 182069

DYNAMO: A PHASE 2 STUDY DEMONSTRATING THE CLINICAL ACTIVITY OF DUVELISIB IN PATIENTS WITH DOUBLE-REFRACTORY FOLLICULAR LYMPHOMA

EHA Library, Pier Luigi Zinzani, 182064

CHEMO-FREE TRIPLET COMBINATION OF TGR-1202, UBLITUXIMAB, AND IBRUTINIB IS WELL TOLERATED AND HIGHLY ACTIVE IN PATIENTS WITH ADVANCED CLL AND NHL

EHA Library, Loretta Nastoupil, 182059